News

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomis...

New Radiation Oncology Services in Howard County - 05/17/2010

Johns Hopkins Medicine and the University of Maryland Medical Center have joined forces to expand regional access to their prominent radiation oncology programs, and to provide cancer patients with state-of-the-art, comprehensive outpatient radiation therapy services at a conveniently located

Missed opportunities for radiotherapy | 6minutes

Some cancer patients are missing out on radiotherapy because their GPs do not explain the benefits or refer them to a radiation oncologist, a WA study suggests.

Breast Cancer Treatment in One Day | PRLog

Breast Cancer Treatment in One Day. Treating breast cancer with radiation at the time of surgery helps patients who meet specific criteria avoid follow-up radiation and resume normal activities - PR11743502

amednews: AMA meeting: Training, EMR tracking can slash risk of radiation overdoses :: Nov. 28,

Delegates support initiatives to better train medical imaging technicians and discourage unnecessary testing.

Isoray: Impressive 98% Success Treating Prostate Cancer - Seeking Alpha

< strong > By < a href='http://seekingalpha.com/user/592211/profile' > John H. Ford < /a > : < /strong > < p > Recently, I started consulting for a company that has the closest thing to a cure for prostate cancer that I have ever seen, and I have been aggressively accumulating shares. Although I

INFINITT Healthcare to Develop the World’s First ‘Integrated Radiation Therapy Management System’

INFINITT Healthcare and Samsung Medical Center collaborates on the world’s radiation oncology development.

Radiotherapy Open Day at the Royal Surrey

< div class= " section " > < a name= " " class= " anchor " > < /a > < h3 class= " heading " > Radiotherapy Open Day at the Royal Surrey < /h3 > < div class= " body " > < div style= " float: right; text-align: right; " class= " media align-right " > < img src= "

CEL-SCI receives key Chinese patent for its investigational cancer therapy Multikine | Pharma Asia

CEL-SCI Corporation announced that the Chinese patent office has issued a key patent covering CEL-SCI’s investigational cancer drug, Multikine (Leukocyte Interleukin, Injection). The patent, Chinese patent number ZL200480025403.6, is titled, “A Method of Pre-Sensitizing Cancer Prior to

Medical News: ASBS: Treatment Affects Risk of DCIS Recurrence - in Surgery, General Surgery from

WASHINGTON -- Women with ductal carcinoma in-situ (DCIS) had a significantly lower recurrence risk when treated with surgery and radiation therapy compared with surgery alone, but recurrences were mor

Results 1-10 of 836
 


Refine by Content Type:

  • Refined by: News  


Refine by Source:

31 Sources ...